![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Treatment eligibility and initiation among chronic hepatitis B
patients in a real-world setting in the United States
|
|
|
EASL 2023 June 21-24 Vienna
Mark A Schmidt¹ | Yihe G Daida² | Sacha Satram³ | Terry Kimes¹ | A Gabriela Rosales¹ | Sixiang Nie² | Richard Meenan¹ | Judy L Donald¹ | Michael A Chattergoon³ | Norah A. Terrault
Center for Health Research, Kaiser Permanente Northwest, Portland, OR | Center for Integrated Health Care Research, Kaiser Permanente Hawaii, Honolulu, HI | Vir Biotechnology, San Francisco, CA | University of Southern California, Los Angeles, CA
![0627231](../images/062723/062623-28/0627231.gif)
![0627232](../images/062723/062623-28/0627232.gif)
![0627233](../images/062723/062623-28/0627233.gif)
![0627234](../images/062723/062623-28/0627234.gif)
![0627235](../images/062723/062623-28/0627235.gif)
![0627236](../images/062723/062623-28/0627236.gif)
![0627237](../images/062723/062623-28/0627237.gif)
![0627238](../images/062723/062623-28/0627238.gif)
![0627239](../images/062723/062623-28/0627239.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|